Pierre‐Dominique Ghislain
Cliniques Universitaires Saint-Luc(BE)UCLouvain(BE)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Drug-Induced Adverse Reactions, Urticaria and Related Conditions
Most-Cited Works
- → Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel(2007)478 cited
- → Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up(2013)406 cited
- → Treatment of severe drug reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and Hypersensitivity syndrome(2002)261 cited
- → Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial(2017)147 cited
- → A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study(2010)111 cited
- → Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from PHOENIX 1(2013)110 cited